2018 Research Grant Call: £2.5 million

We’re proud to have awarded £2.5 million in research grants for childhood cancer causes and prevention.

hands with gloves pipetting cells

Project Details

  • In 2018, £2.5 million funded nine projects researching childhood cancer causes and prevention.
  • Grant Call
  • 2018
  • Funding Total
  • £2,554,392
  • Projects Funded
  • 9
  • Start Date
  • 18 Jul 2019
  • Project Duration
  • 16 Sep 2019

Overview

Children with Cancer UK invited proposals for research projects that addressed causal and promotional factors and possible preventative actions relating to the risk of cancer in children and young persons.

  • Deadline for preliminary proposals: 25 January 2019
  • Received 34 preliminary proposals
  • Following triage by our Scientific Advisory Panel, 9 applicants were invited to submit full proposals
  • Final review was held on 18 July 2019
  • Grants announced on 16 September 2019

Our panel included world-renowned experts in childhood cancer and environmental risk factors

  • Mr Alasdair Philips
  • Professor Denis Henshaw
  • Dr Kurt Straif
  • Dr Isabelle Soerjomataram
  • Chair: Professor Geoff Pilkington

The following 9 projects were awarded grants, totalling £2,554,392

  • Professor Dudley Shallcross
  • Host institution: University of Bristol
  • Grant Title: Assessment of potential health impacts from transplacental exposure to carcinogenic air pollutants
  • Grant total: £349,833
  • Professor John Wright
  • Host institution: Bradford Teaching Hospitals NHS Foundation Trust
  • Grant Title: Does maternal ambient air exposure to traffic-related particulate matter induce carcinogenic responses in the foetus?
  • Grant total: £350,000
  • Dr Eva Steliarova-Foucher
  • Host institution: International Agency for Research on Cancer
  • Grant Title: Cancer risk in childhood cancer survivors (CRICCS): understanding the causes to target prevention
  • Grant total: £349,400
  • Dr Fiorella Belpoggi
  • Host institution: Cesare Maltoni Cancer Research Center, Ramazzini Institute
  • Grant Title: Early exposure to radio-frequency electromagnetic fields and cancer: complete evaluation of the Ramazzini Institute long-term carcinogenicity bioassays on Sprague-Dawley rats
  • Grant total: £180,060
  • Professor Marco Vinceti
  • Host institution: University of Modena and Reggio Emilia
  • Grant Title: Motorized Traffic and Risk of Childhood Leukaemia
  • Grant total: £222,500
  • Dr Michael Scheurer
  • Host institution: Baylor College of Medicine
  • Grant Title: Timing and Duration of Breastfeeding and Childhood Brain Tumor Risk
  • Grant total: £332,838
  • Dr Xiaomei Ma
  • Host institution: Yale University
  • Grant Title: Interaction between ionising radiation and genetic susceptibility in the aetiology of childhood acute lymphoblastic leukaemia
  • Grant total: £158,870.40
  • Professor Thomas Seyfried
  • Host institution: Trustees of Boston College
  • Grant Title: Investigating metabolic mechanisms driving childhood brain cancer
  • Grant total: £451,891.70
  • Professor Catherine Metayer
  • Host institution: The Regents of the University of California
  • Grant Title: Folate metabolism and risk of childhood leukaemia: a biomarker study
  • Grant total: £391,648
Zoe Walters 5

Identifying new treatments for children with rhabdomyosarcoma

Related research – Dr Zoë Walters

Every year in the UK around 55 children are diagnosed with rhabdomyosarcoma, a cancer that affects connective tissues such

Accelerating the delivery of personalised treatment to children with neuroblastoma using MRI

Related research – Dr Yann Jamin

Using biomarkers has helped to improve response rates in adult cancers from 4-50%. We urgently need to get new treatments

scientist

Studying the role of ATRX in ALT positive cancers

Related research – Dr David Clynes

Cancers known as ALT positive include some incurable brain tumours that affect children. Our research project aims to uncover more

Other stories

We have lots of information to help you learn more about childhood cancer. From specific cancer types, to treatments and causes.